Most Recent
Property manager Meriton is appealing a $3 million fine for misleading consumers by manipulating negative TripAdvisor reviews.
Global pharmaceutical giant Sanofi-Aventis has launched patent infringement proceedings against generic drug maker Alphapharm seeking "urgent interlocutory relief" to prevent a generic injector pen from being listed on the market.
A patent application for a computer-implemented invention filed by Apple may have a shot at approval, with a delegate for IP Australia saying strict tests for patentability should be eschewed in favor of a more holistic approach.
A jury has found the former managing director of South Australian mining exploration company Golden Fields Resources guilty of two counts of insider trading, the corporate regulator said Tuesday.
Plastic banknote company Securency has been ordered to pay more than $64 million after it tricked its agent in Nigeria into signing away his commission in what the Federal Court called a "shabby fraud".
Fundraising company Appco Group Australia has failed in its bid to put a massive sham contracting class action in the Federal Court on hold while it fights a ruling that let the case continue as a representative proceeding.
A helicopter passenger who suffered serious injuries in an accident near Alice Springs has lost a challenge to the dismissal of his case, with an appeals court ruling a Slater & Gordon lawyer's defective statement of claim -- lodged on the last day of the limitations period -- was not accepted by a registry of the Northern Territory Supreme Court.
The two coal companies at the centre of an ACCC case alleging an unlawful agreement to rig the tender process for mining exploration licenses were not competitors, a judge has ruled in dismissing the watchdog's cartel case.
Lawyers on both sides of the class action against American Medical Services over pelvic mesh implants have taken steps to ensure the case proceeds with greater efficiency than the pelvic mesh class action against Johnson & Johnson, which went to an 89-day trial five years after that case was filed.
A Federal Court judge skipped vital witness testimony when he ruled Reckitt Benckiser misled consumers about the effectiveness of its Nurofen painkiller, the pharmaceutical company told the Full Federal Court Monday.